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Abstract
Background: Process evaluations of randomised controlled trials (RCTs) can provide insight and inform us on the intervention
implementation, the causal mechanisms and the contextual factors. This will inform about interventions’ success or failure due
to their implementation or the interventions themselves. We aim to consolidate the methodology from previous process
evaluations of complex interventions upon their findings on facilitators and barriers to address the prevention of type 2 diabetes
mellitus among women with gestational diabetes mellitus (GDM).
Methods: Comprehensive search will be conducted on electronic databases and reference lists of recent reviews for RCTs of
complex interventions which address process evaluations of diabetes prevention intervention (DPI) for women with GDM in
healthcare settings. There is no restriction on the language of the papers and year of publication until December 2020. Data
from each study will be extracted by two reviewers independently using standardised forms. Data extracted include descriptive
items on the study design and the outcomes of process evaluations from the three dimensions: (1) implementation; (2)
mechanism of impact and (3) context. The quality of the studies will be assessed using mixed methods appraisal tool which is
designed for the appraisal of mixed studies in systematic reviews. A narrative and framework analysis of the findings will be
presented to inform the contents of a new DPI for women with GDM.
Discussion: The findings from this process evaluation findings are valuable in determining whether a complex intervention
should be scaled up or modified for other contexts in future plan. It will give deeper understanding of potential challenges and
solutions to aid in the implementation of effective DPIs for GDM in Malaysia.
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Background
Gestational diabetes mellitus (GDM) is a condition that occurs
when there is impairment in glucose tolerance during preg-
nancy, with 84% of diabetes in pregnancy being GDM
(International Diabetes Atlas, 2019). The worldwide preva-
lence of GDM ranged from 7.5% to 27% in 2019 with the
incidence of GDM continuing to increase, especially in low to
middle income countries (International Diabetes Atlas, 2019).
For example, 1 in 4 live births in South East Africa were
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affected by GDM compared to 1 in 6 live births in Europe. In
Malaysia, the prevalence of GDM ranges 7.71%–27.9% (4th
Report of National Obstetric Registry, 2013–2015;
International Diabetes Atlas, 2019; Logakodie et al, 2017).
The maternal consequences of GDM are wide ranging in-
cluding obstetric complications such as pre-eclampsia and a
2–7 fold increased risk of having future episodes of GDM and
developing type 2 diabetes (T2D) (Bellamy et al., 2009;
Reece, 2010) and increased risk of cardiovascular diseases
(Lekva et al., 2015). For instance, the International Hyper-
glycaemia and Adverse Pregnancy Outcomes study found that
around half of the women with GDM developed T2D or
prediabetes 11 years later (Hapo Study Cooperative Research
Group, 2010). The risk factors for this conversion include
maternal age, glucose levels in pregnancy, family history of
diabetes, pre-pregnancy and postpartum body mass index,
dietary patterns, physical activity, breastfeeding and genetic
predisposition (Davis et al., 2017; Gunderson et al., 2015; Liu
et al., 2014). Women with GDM are also more likely to have
antenatal and postnatal depression than those without GDM
(Napoli et al., 2020; Wilson et al., 2020).
There are also potential adverse outcomes for the infant
such as shoulder dystocia, neonatal hyperbilirubinaemia,
hypoglycemia and respiratory distress syndrome (Bhandiwad
et al., 2015) in the short term and increased risk of T2D in the
long term (Lowe et al., 2018).
As women receive more medical attention during the
antenatal and postpartum period than any other stage in their
life course, this represents an important window of oppor-
tunity for prevention of T2D post-GDM. While randomised
controlled trials (RCTs) have shown that intensive diabetes
prevention intervention (DPI) is more effective in reducing
T2D risk than usual care in the general population (Diabetes
Prevention Program Research Group, 2015; Gong et al.,
2019; Tuomilehto et al., 2001), RCTs of DPIs for women
with GDM have to date been less effective in preventing
future GDM episodes or T2D. There have been approxi-
mately 30 such RCTs in the past 10 years. A recent meta-
analysis in women with GDM reported mixed results; of the
15 RCTs included in the review, in 8 studies that could be
pooled, there was a non-significant reduction in risk for T2D
(risk ratio = 0.75, 95% confidence interval (CI) 0.55–1.03
(Goveia et al., 2018). More recent RCTs have reported a
small non-significant mean reduction in weight over
12 months (Liu et al., 2018) and a non-significant reduction
in T2D at 3 years (Shek et al., 2014).
There is a need to understand why current models of DPI in
GDM women are of limited effectiveness. As DPIs are, in
effect, complex interventions made up of multiple components
or active ingredients (Craig et al., 2008), one approach could
be is to critique the process evaluation (Moore et al., 2015).
This is an umbrella term for a range of theoretical constructs
and methodologies that aim to identify the key components of
a complex intervention that help explain how and why they are
(or are not) effective.
The Medical Research Council (MRC) by Moore et al.
(2015) has produced a theoretical framework that describes
three dimensions of a process evaluation (see Figure 1). The
first dimension is implementation where it identifies the
process through which the interventions are delivered and
what is delivered in real practice. In the implementation di-
mension, it does include the theoretical framework and be-
haviour change technique used, the dosage to define how
much intervention delivered and received, the reach to which
the audience comes into contact with the intervention and the
fidelity such as the consistency of the planned and real in-
tervention. Second dimension of the process evaluation is the
mechanism of impact which aims to explain the pathway
through which intervention activities produce intended (or
unintended) effects. The study of mechanisms may include
participant or therapist responses to interaction with a complex
intervention and examining mediating or intermediate pro-
cesses which explain subsequent changes in outcomes, in-
cluding those unintended. The last dimension is the context in
which the intervention is set. This includes moderating factors
external to the intervention but that may influence its im-
plementation, such as health policy, organisational factors or
changes in delivery of medical care, socio-cultural factors
such as stigma or cultural values, lack of support to attend the
complex intervention and psychological factors such as shame
or health beliefs.
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In summary, process evaluations use quantitative and/or
qualitative methods to examine these three dimensions (im-
plementation, mechanisms of action and contextual factors)
will help to identify the active ingredients in the RCTs
(Anderson et al., 2013).
There has been no systematic review of process evalua-
tion in RCTs of DPI in the healthcare settings and general
population. However, processes that are most commonly
reported in these DPIs often include nutritional advice and/or
physical activity; behaviour change techniques such as goal
setting and motivational interviewing; target setting such as
aiming for 5–7% weight loss; specialist healthcare providers
such as health trainers; ‘dose’ in terms of number of sessions
and duration of the intervention and pacing of sessions such
as initial high frequency of sessions followed by less frequent
maintenance phases. In contrast, the majority of the DPI
processes for GDM included diet and physical advice
(Goveia et al., 2018). There was tentative suggestion that
those DPIs which started soon after delivery were more
effective (risk ratio = 0.61, 95% CI 0.40–0.94). There have
been less than a handful of RCTs that have used breast-
feeding as an intervention.
This study therefore first aims to conduct a systematic
review of the processes evaluated in RCTs of DPIs in GDM;
second to describe the range of processes assessed and the
methods used to do so; third to identify processes that overall
appear to be a) more effective and b) not effective in reducing
the risk of T2D post GDM. These findings will inform the
content of a DPI for women with GDM in Malaysia.
Methodology
Design and Registration
We will conduct the systematic review in accordance with
Preferred Reporting Items for Systematic reviews and Meta-
Analyses Protocol (PRISMA) guidelines from Moher et al.
(2009) (see Figure 2) and checklist (see appendix). The
systematic review is prospectively registered with PROS-
PERO (Registration number: CRD42020208212) and
amendments will be documented with version description.
Eligibility Criteria
Types of studies. Only RCTs will be included; cohort and
uncontrolled before-and-after studies, case series, reviews,
non-journal article, non-report based on empirical research
and non-human research will be excluded. We will aim to
extract process evaluation findings from all RCTs whether or
not these have been explicitly described as some RCTs do
include some aspects of process evaluation.
Types of patients. The patient group will consist of women
who have current or a history of GDM. Women at high risk of
GDM such as those with obesity, family history of T2D,
menopausal and post-menopausal women will be excluded.
Types of intervention. The interventions included will be
complex interventions consisting of lifestyle change delivered
either in the antenatal and/or postnatal period through
Figure 1. Conceptual framework (adapted from Medical Research Council guidance on process evaluations by Moore et al. (2015).
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digitalised, face-to-face or mixed methods intervention during
the antenatal and/or postnatal period. It includes dietary
management, physical activity, psychological aspect and
others. Interventions that test a single ingredient, for example,
a pharmacological agent will be excluded.
The comparators. It may include treatment as usual, active
control or placebo control. Placebo controlled is a condition
where one that appears in all respects to be identical to the
treatment condition and lacking on the critical ingredient of the
treatment. Meanwhile, an active control is one in which par-
ticipants engage in some task during the intervention period.
Types of outcome. The primary outcome will be the strengths
and limitations of each process evaluation as well as the
identification of implementation barriers and facilitators for the
complex intervention following MRC guidance as a reference
point. Quantitative and qualitative data will be extracted, coded
and grouped into categories of implementation, mechanism of
impact and context dimensions and their related constructs. In
the implementation dimension, the following constructs will be
assessed: the description on the type of intervention and control;
the process through which the intervention delivery is achieved;
the theoretical framework and behaviour change technique used
to inform the intervention; the reach to the extent the target
audience comes into contact with the intervention; dosage
(number of sessions or total time) delivered and received and
the fidelity which include the constancy of delivering according
to the protocol and competency in delivering them. In the
mechanism of impact dimension, the following will be
extracted: format of delivery (digital, non-digital or hybrid);
participant and healthcare provider experience towards the
complex intervention as well as any intended or unintended
process which explain subsequent changes in the outcomes.
Whereas in the context dimension, we will extract data on the
socio-cultural; organisational, local and national policy factors
(such as barriers, facilitators, contamination and adoption)
which may influence the intervention implementation, inter-
vention mechanisms and its outcomes. Inductive derivation of
the key themes done through constant comparison between the
findings from the papers within each category and examining
the relationships between them. The secondary outcomes we
will extract include maternal rates of T2D and of subsequent
episodes of GDM; risk factor for T2D (weight, blood sugar
profile and lipid profile); psychological issue; mother–infant
relationship; maternal complications and infant complications.
Figure 2. Preferred Reporting Items for Systematic Review and Meta-Analyses: RCT randomised controlled trial.
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Information Sources
We will search from the following databases: OVID (EMBASE,
MEDLINE, PsycINFO and Global Health), Cochrane Library,
PUBMED and hand-searching of reference lists of recent re-
views (Goveia et al., 2018; Miyazaki et al., 2017). There is no
restriction on the language of the papers and year of publication
until December 2020. For each RCT included in this review, we
will specifically search for duplicates and secondary publica-
tions, and contacting all the authors to request any published or
unpublished process evaluation. Forward and backward citation
will also be used to screen for eligible articles.
Search Strategy
The keywords will be developed and iteratively refined from the
research questions and definitions of key concepts by using
Cochrane search terms for diabetes prevention, GDM and
lifestyle interventions including antenatal, postnatal, breast-
feeding, T2D, randomised control trial and process evaluations.
The main key words used will be GDM, randomised controlled
trial and process evaluation. Boolean search will be used to
combine the keywords with operators such as AND, NOT and
OR to further produce more relevant results. For example:
((GDMOR gestational diabetes OR pregnancy-induced diabetes
OR diabetes in pregnancy) AND ((RCT OR controlled clinical
trial OR pragmatic control trial OR clinical trial) AND (process
evaluation OR programme evaluation OR process assessment
OR process acceptance OR outcome measures)); ((GDMs OR
gestational diabetes OR pregnancy-induced diabetes)) AND
((RCTOR controlled clinical trial OR pragmatic clinical trial OR
clinical trial) OR (process evaluation OR programme assessment
OR process acceptance OR outcome measures).
Data Management
Rayyan QCRI will be used for title and abstract screening.
Duplicate papers will be identified and removed accordingly
from search strategy database and EndNote. Two authors will
independently assess the eligibility of the publications based
first on the titles and abstracts of records identified by the
searches. After excluding papers that do not meet eligibility
criteria based on titles and abstracts, the remaining publications
will be downloaded for further assessment of eligibility. Data
will be stored in a common file which will be password pro-
tected. Non-English language papers will be translated into
English by bilingual professionals or academics. The reviewers
will resolve disagreements as to eligibility through a consensus-
based discussion, and if necessary, with a third reviewer.
Standardised Data Extraction
The following data about the RCT will be extracted: general
information of the study (author, title of the study, year and type
of publication, aim of the studies, studies country, economy
level, funding sources and conflict of interest); methodology
(study population description, sample size, type of study, source
and setting of the population, sampling population, inclusion
and exclusion criteria, sampling technique, study measurement
and instrument as well as instruments validity and reliability);
study duration (study start date and study end date); results
(primary findings, secondary findings, response rate, attrition
rate, effect sizes, participant’s characteristic results such as age,
ethnicity, marital status, parity, type of birth, education and
employment) and summary (discussion, conclusion, strength,
limitation, future recommendation and risk of bias assessment).
The outcomes we will extract include: maternal rates of T2D
and of subsequent episodes of GDM; risk factor for T2D
(weight, blood sugar profile and lipids profile); psychological
issue (depression); mother–infant relationship and other ma-
ternal and infant complications.
In terms of the process evaluation aspects, the MRC
provides many examples of processes but there is no con-
sensus for a gold standard or a minimum checklist for process
evaluation. Therefore, we have derived a checklist of process
constructs within the three dimensions. Qualitative and
quantitative data will be extracted for each construct. In the
implementation dimension, the following constructs will be
assessed: the theoretical framework used to inform the in-
tervention; an assessment of reach; dose (number of sessions
or total time) delivered; dose received; fidelity of delivering
protocol as stated; description of behaviour change techniques
and competency in delivering them. In the mechanistic di-
mension, the following will be extracted: format of delivery
(digital, non-digital or hybrid); participant experience and
health provider experience. Digital interventions will include
the use of telephone, video-conferencing, mobile short mes-
sage service (SMS), apps or web-based interfaces and other
remote wireless relay systems (Moore et al., 2015). In the
contextual factors, we will extract data on external factors such
as socio-cultural, organisational, local and national policy
factors (such as barriers, facilitators, contamination and
adoption) which may influence the implementation and
mechanism of the DPI. The data extraction forms will be pilot
tested by the two reviewers and iteratively revised. Two re-
viewers will independently extract data from the rest of the
included list of articles.
Quality Assessment
Data to assess quality will be extracted from the included
studies. Quality assessment tool or risk of bias tool uses scale
or checklist which provides a list of criteria or domain in order
to appraise quality of the study (Pace et al., 2012; Pluye &
Hong, 2014). Hence, a unique tool known as Mixed Method
Appraisal Tool by Hong et al. (2018) will be used to assess the
quality of different study designs (see Figure 3). This tool is
about judgement making by the reviewers. For each included
study, it is necessary for the reviewer to choose appropriate
category of studies to appraise. Then, rate the criteria of the
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chosen category accordingly. For each criterion, a yes or no
(Pace et al., 2012; Pluye & Hong, 2014) may be scored as 1 or
0, respectively. The ‘cannot tell’ response category indicates
that the paper do not report appropriate information to answer
‘yes’ or ‘no’ and the reviewer would look for companion
papers or contact the authors for more information or clari-
fication. In terms of scoring (https://bit.ly/2VwFzkA), the
overall score can be presented using descriptors such as * or
%. The number of * will reflect the number of quality criteria a
study has met. For quantitative and qualitative studies, an *
(20%) is for meeting one criterion, and ***** (100%) are for
meeting all five criteria. For mixed methods studies, the same
scoring is applied to each of the qualitative, quantitative and
mixed methods component. The component with the lowest
score will reflect the overall quality of a mixed methods study.
The quality rating of each study and criterion will be supported
with explanatory notes to better inform the quality of the
included studies (Hong et al. 2018). This may lead to a
sensitivity analysis such as comparing the quality of studies by
contrasting their results *, **, ***, and ****.
Data Synthesis and Outputs
The extracted qualitative and quantitative data for each of the
three MRC process evaluation dimensions will be summarised.
In quantitative part, descriptive items (i.e., number of positive
RCTs) will be tallied and synthesised into three tables: (1)
Overall characteristics of the study; (2) methodology: stages of
the process evaluation will be gathered and grouped among the
studies grouping (i.e., feasibility/piloting, effectiveness and post-
evaluation) and (3) quality assessment: using a tool developed by
the Effective Public Health Practice Project for knowledge
synthesis which provides a standardised means to assess study
quality and overall methodological rating of either strong,
moderate or weak category for evidence support practice.
Meanwhile for the qualitative part, framework analysis will be
used to extract the data from all of the dimensions. It is a matrix-
based method involving the construction of thematic categories
into which data can be coded (Ritchie et al., 1994). Framework
analysis can be flexible during the analysis process where it
allows the user to both collect all the data and then analyse it or
do data analysis during the collection process. In the analysis
stage, the gathered data are sifted, charted and sorted in ac-
cordance with key issues and themes. Hence, the extracted data
will be coded and grouped accordingly into sub-components for
each dimension of implementation, mechanism of impact and
implementation. The key themes derivation will be identified
through reasoning and constant comparison between the findings
from the collective papers within each category by examining the
relationships between them. One practical feature of framework
analysis is that it enables questions or issues identified in advance
by various stakeholders (such as policymakers, practitioners or
user groups) to be explicitly and systematically considered in the
analysis, while also facilitating enough flexibility to detect and
characterise issues that emerge from the data. Using a modified
MRC framework, we will map our methodological and im-
plementation findings to triangulate and synthesise the data.
Triangulation takes part as a method to develop comprehensive
understanding and to act as a strategy to test the validity through
the convergence of information from different sources of the
Figure 3. Mixed methods appraisal tools, 2018.
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data. These categories of data information will then be subjected
to thematic synthesis in order to produce a comprehensive set of
synthesised findings (Tong et al., 2012). Throughout the review,
patient and public perspectives are synthesised from published
papers, and hence, no public and patients were directly involved
in this study. The findings will be synthesised according to each
aim and will be used to inform the contents of a new DPI for
women with GDM in Malaysia.
Discussion
There have been approximately 30 RCTs of complex lifestyle
interventions to reduce the risk of T2D in women with GDM yet
collectively the evidence for the effectiveness of these inter-
ventions remains limited. Before conducting another RCTof DPI
in this high-risk group, it is important to understand why previous
RCTs have either had negative or weak effects. Process evaluation
integrated into RCTs of complex interventions capture an um-
brella of concepts to help explain the underlying mechanisms of
action. They vary in their objectives, methodology and the se-
lection of outcome and there is no consensus as yet as to how best
to conduct them.We have proposed a framework for a systematic
review that will extract and summarise what processes have been
evaluated under the three key MRC dimensions of im-
plementation, mechanism and context. We will use the findings
to inform the development of a logic model, the contents of a
digital app and derive a process evaluation framework for our
future feasibility study testing of a refined DPI.
The strengths of this protocol include that it sets out a priori
a systematic review using a comprehensive approach to in-
clude all RCTs regardless of whether the term process eval-
uation is explicitly described. As there is no validated
consensus checklist to conduct a process evaluation, we have
adapted other models (Grant et al., 2013; Saunders, 2006). We
have proposed a pragmatic checklist of key processes using
widely accepted current theories and national guidance
(Moore et al., 2015).
The limitations are that wemay have unintentionally omitted
one or more relevant processes, but we aim to reduce this risk
by piloting the data extraction schedule with several RCTs and a
priori revising the protocol if new processes are identified
during the review. There are some frameworks we could have
used instead such as the Wagner Chronic Care model which six
interdependent elements of a complex intervention, namely, the
Health System: The Community: Self-Management Support:
Decision Support: Delivery System Design: and Clinical In-
formation Systems, but they do not give guidance on the
methods for assessing the processes (Barr et al., 2003).
Conclusion
In summary, we have devised a protocol for a systematic
review of process evaluations for DPI for GDM, and the
findings are potentially informative for other lifestyle
interventions to reduce chronic diseases such as obesity,
cardiovascular diseases and depression.
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